Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money.
Today we look at two noteworthy recent insider buys.
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money.
Today we look at two noteworthy recent insider buys.
At Relay Therapeutics, a filing with the SEC revealed that on Monday, Director Douglas S.
Ingram purchased 25,000 shares of RLAY, for a cost of $20.00 each, for a total investment of $500,000.
So far Ingram is in the green, up about 104.6% on their buy based on today's trading high of $40.92.
Relay Therapeutics Inc is trading down about 4.5% on the day Wednesday.
And at Ennis, there was insider buying on Tuesday, by Director Barbara T.
Clemens who bought 1,600 shares for a cost of $16.82 each, for a total investment of $26,912.
Ennis is trading up about 2.1% on the day Wednesday.
So far Clemens is in the green, up about 5.1% on their buy based on today's trading high of $17.68.